420 related articles for article (PubMed ID: 27768970)
1. Polymeric nanoparticles promote macrophage reversal from M2 to M1 phenotypes in the tumor microenvironment.
Wang Y; Lin YX; Qiao SL; An HW; Ma Y; Qiao ZY; Rajapaksha RP; Wang H
Biomaterials; 2017 Jan; 112():153-163. PubMed ID: 27768970
[TBL] [Abstract][Full Text] [Related]
2. Targeted depletion of tumour-associated macrophages by an alendronate-glucomannan conjugate for cancer immunotherapy.
Zhan X; Jia L; Niu Y; Qi H; Chen X; Zhang Q; Zhang J; Wang Y; Dong L; Wang C
Biomaterials; 2014 Dec; 35(38):10046-57. PubMed ID: 25245263
[TBL] [Abstract][Full Text] [Related]
3. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
[No Abstract] [Full Text] [Related]
4. Selectively targeting tumor-associated macrophages and tumor cells with polymeric micelles for enhanced cancer chemo-immunotherapy.
Wei X; Liu L; Li X; Wang Y; Guo X; Zhao J; Zhou S
J Control Release; 2019 Nov; 313():42-53. PubMed ID: 31629039
[TBL] [Abstract][Full Text] [Related]
5. Target delivery selective CSF-1R inhibitor to tumor-associated macrophages via erythrocyte-cancer cell hybrid membrane camouflaged pH-responsive copolymer micelle for cancer immunotherapy.
Wang Y; Luan Z; Zhao C; Bai C; Yang K
Eur J Pharm Sci; 2020 Jan; 142():105136. PubMed ID: 31704343
[TBL] [Abstract][Full Text] [Related]
6. Intratumoral Delivery of IL-21 Overcomes Anti-Her2/Neu Resistance through Shifting Tumor-Associated Macrophages from M2 to M1 Phenotype.
Xu M; Liu M; Du X; Li S; Li H; Li X; Li Y; Wang Y; Qin Z; Fu YX; Wang S
J Immunol; 2015 May; 194(10):4997-5006. PubMed ID: 25876763
[TBL] [Abstract][Full Text] [Related]
7. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.
Qian Y; Qiao S; Dai Y; Xu G; Dai B; Lu L; Yu X; Luo Q; Zhang Z
ACS Nano; 2017 Sep; 11(9):9536-9549. PubMed ID: 28858473
[TBL] [Abstract][Full Text] [Related]
8. Reprogramming Tumor-Associated Macrophages by Nanoparticle-Based Reactive Oxygen Species Photogeneration.
Shi C; Liu T; Guo Z; Zhuang R; Zhang X; Chen X
Nano Lett; 2018 Nov; 18(11):7330-7342. PubMed ID: 30339753
[TBL] [Abstract][Full Text] [Related]
9. IL-4 blockade alters the tumor microenvironment and augments the response to cancer immunotherapy in a mouse model.
Ito SE; Shirota H; Kasahara Y; Saijo K; Ishioka C
Cancer Immunol Immunother; 2017 Nov; 66(11):1485-1496. PubMed ID: 28733709
[TBL] [Abstract][Full Text] [Related]
10. M1 Macrophage-Derived Nanovesicles Potentiate the Anticancer Efficacy of Immune Checkpoint Inhibitors.
Choo YW; Kang M; Kim HY; Han J; Kang S; Lee JR; Jeong GJ; Kwon SP; Song SY; Go S; Jung M; Hong J; Kim BS
ACS Nano; 2018 Sep; 12(9):8977-8993. PubMed ID: 30133260
[TBL] [Abstract][Full Text] [Related]
11. Targeted Delivery of miRNA 155 to Tumor Associated Macrophages for Tumor Immunotherapy.
Zang X; Zhang X; Zhao X; Hu H; Qiao M; Deng Y; Chen D
Mol Pharm; 2019 Apr; 16(4):1714-1722. PubMed ID: 30860846
[TBL] [Abstract][Full Text] [Related]
12. A simple and powerful co-delivery system based on pH-responsive metal-organic frameworks for enhanced cancer immunotherapy.
Duan F; Feng X; Yang X; Sun W; Jin Y; Liu H; Ge K; Li Z; Zhang J
Biomaterials; 2017 Apr; 122():23-33. PubMed ID: 28107662
[TBL] [Abstract][Full Text] [Related]
13. Self-Assembled Nanoparticles from the Amphiphilic Prodrug of Resiquimod for Improved Cancer Immunotherapy.
Li JX; Shu N; Zhang YJ; Tong QS; Wang L; Zhang JY; Du JZ
ACS Appl Mater Interfaces; 2024 May; 16(20):25665-25675. PubMed ID: 38735053
[TBL] [Abstract][Full Text] [Related]
14. Tumor promoting role of anti-tumor macrophages in tumor microenvironment.
Goswami KK; Ghosh T; Ghosh S; Sarkar M; Bose A; Baral R
Cell Immunol; 2017 Jun; 316():1-10. PubMed ID: 28433198
[TBL] [Abstract][Full Text] [Related]
15. Dendrosomal curcumin suppresses metastatic breast cancer in mice by changing m1/m2 macrophage balance in the tumor microenvironment.
Shiri S; Alizadeh AM; Baradaran B; Farhanghi B; Shanehbandi D; Khodayari S; Khodayari H; Tavassoli A
Asian Pac J Cancer Prev; 2015; 16(9):3917-22. PubMed ID: 25987060
[TBL] [Abstract][Full Text] [Related]
16. Diverse macrophages polarization in tumor microenvironment.
Rhee I
Arch Pharm Res; 2016 Nov; 39(11):1588-1596. PubMed ID: 27562774
[TBL] [Abstract][Full Text] [Related]
17. The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure.
Lima L; Oliveira D; Tavares A; Amaro T; Cruz R; Oliveira MJ; Ferreira JA; Santos L
Urol Oncol; 2014 May; 32(4):449-57. PubMed ID: 24252833
[TBL] [Abstract][Full Text] [Related]
18. M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma.
Jarosz-Biej M; Kamińska N; Matuszczak S; Cichoń T; Pamuła-Piłat J; Czapla J; Smolarczyk R; Skwarzyńska D; Kulik K; Szala S
PLoS One; 2018; 13(1):e0191012. PubMed ID: 29320562
[TBL] [Abstract][Full Text] [Related]
19. Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype.
Chen D; Xie J; Fiskesund R; Dong W; Liang X; Lv J; Jin X; Liu J; Mo S; Zhang T; Cheng F; Zhou Y; Zhang H; Tang K; Ma J; Liu Y; Huang B
Nat Commun; 2018 Feb; 9(1):873. PubMed ID: 29491374
[TBL] [Abstract][Full Text] [Related]
20. Macrophage repolarization with targeted alginate nanoparticles containing IL-10 plasmid DNA for the treatment of experimental arthritis.
Jain S; Tran TH; Amiji M
Biomaterials; 2015 Aug; 61():162-77. PubMed ID: 26004232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
